PQ 332
332. Deputy Erin McGreehan asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy. [38500/26]
Introduced
21 May 2026
Last action
21 May 2026 · Medicinal Products
Status
written
Sponsors
Erin McGreehan
Subjects
Discovery layer
Source updated
21 May 2026
Summary
332. Deputy Erin McGreehan asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy. [38500/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 May 2026
Medicinal Products
332. Deputy Erin McGreehan asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy. [38500/26]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 21 May 2026
Sponsors
- Erin McGreehan · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-05-21/332/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-05-21/pq_332
- ireland · q-2026-05-21-pq_332 · source updated 21 May 2026